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MaOBJECTIVES The aim of this study was to develop a 3-dimensional (3D) fusion tool kit to integrate left ventricular (LV)
venous anatomy on ﬂuoroscopy venograms with LV epicardial surface on single-photon emission computed tomography
(SPECT) myocardial perfusion imaging (MPI) for guiding cardiac resynchronization therapy (CRT) LV lead placement.
BACKGROUND LV lead position is important for CRT response. For LV lead placement into viable regions with late
activation, it is important to visualize both LV venous anatomy and myocardium.
METHODS Major LV veins were manually identiﬁed on ﬂuoroscopic venograms and automatically reconstructed into a
3D anatomy. 3D LV epicardial surface was extracted from SPECT MPI. SPECT-vein fusion that consisted of geometric
alignment, landmark-based registration, and vessel-surface overlay was developed to fuse the 3D venous anatomy with
the epicardial surface. The accuracy of this tool was evaluated using computed tomography (CT) venograms. LV
epicardial surfaces and veins were manually identiﬁed on the CT images and registered with the SPECT image by an
independent operator. The locations of the ﬂuoroscopic and CT veins on the SPECT epicardial surfaces were compared
using absolute distances on SPECT short-axis slice and the 17-segment model.
RESULTS Ten CRT patients were enrolled. The distance between the corresponding ﬂuoroscopic and CT veins on the
short-axis epicardial surfaces was 4.6  3.6 mm (range 0 to 16.9 mm). The presence of the corresponding ﬂuoroscopic
and CT veins in the 17-segment model agreed well with a kappa value of 0.87 (95% conﬁdence interval: 0.82 to 0.93).
The tool kit was used to guide LV lead placement in a catheter laboratory and showed clinical feasibility and beneﬁt to
the patient.
CONCLUSIONS A tool kit has been developed to reconstruct 3D LV venous anatomy from dual-view ﬂuoroscopic
venograms and to fuse it with LV epicardial surface on SPECT MPI. It is technically accurate for guiding LV lead
placement by the 17-segment model and is feasible for clinical use in the catheterization laboratory. (J Am Coll Cardiol
Img 2014;7:1239–48) © 2014 by the American College of Cardiology Foundation.L eft ventricular (LV) lead location is an essentialfactor for patient response to cardiac resynch-ronization therapy (CRT) (1). It is important
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TABLE 1 Pre-CRT Baseline Characteristics of Study
Population (N ¼ 10)
Age, yrs 60  10
Sex
Male 7
Female 3
LVEF, % 30.1  5.0
QRS duration, ms 184  16
NYHA functional class
II 4
III 5
IV 1
Type of cardiomyopathy
Ischemic 2
Nonischemic 8
Values are mean  SD or n.
CRT ¼ cardiac resynchronization therapy; LVEF ¼ left ventricular ejection
fraction; NYHA ¼ New York Heart Association.
ABBR EV I A T I ON S
AND ACRONYMS
AP = anteroposterior
AV = anterior vein
CMR = cardiac magnetic
resonance
CRT = cardiac
resynchronization therapy
CS = coronary sinus
GCV = great cardiac vein
LAO = left anterior oblique
LMV = left marginal vein
LV = left ventricular
MCV = middle cardiac vein
MPI = myocardial perfusion
imaging
PV = posterior vein
SPECT = single-photon
emission computed
tomography
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1240tomography (SPECT) myocardial perfusion
imaging (MPI) to identify the optimal LV lead
positions. In that study, a concordant LV lead
position was deﬁned as the LV lead placed in
the segment with myocardial viability and
with or adjacent to the latest mechanical acti-
vation. That study showed that 96% of the
patients, who had baseline mechanical dys-
synchrony, acceptable scar burden (<40%),
and a concordant LV lead position, had favor-
able acute CRT response and long-term
outcome (3). Other imaging modalities, such
as cardiac magnetic resonance (CMR) (4) and
echocardiography (5,6), were also used to
attempt optimization of LV lead positions for
potential improvement in CRT response.
All of the mentioned imaging studies iden-
tiﬁed the optimal LV lead position on the
myocardial wall, which is not visualized on
x-ray ﬂuoroscopy venograms during implan-
tation. The LV lead positions recommendedon the myocardial wall may not contain any suitable
venous branches for LV lead placement. Furthermore,
implanters may not accurately correspond the venous
anatomy with the myocardial wall segmentation. Such
inaccurate correspondence may result in suboptimal
or inappropriate LV lead positions because changes of
LV lead position by approximately 20mmcould impact
CRT response (7). The TARGET (Targeted Left Ven-
tricular Lead Placement to Guide Cardiac Resynchro-SEE PAGE 1249nization Therapy) trial reported that LV leads were not
optimally placed in 37% of the patients in the guided
group, even if the implanters knew the target regions
given by echocardiography before implantation (6).
Consequently, the CRT response rate in the guided
group was 70%, marginally better than that found in
current practice. Therefore, visualization of LV
myocardial wall and recommended LV lead positions
by myocardial imaging techniques during implanta-
tion is critical for image-guided LV lead placement.
The objectives of this study were to develop a
3-dimensional (3D) fusion tool kit to integrate LV
venous anatomy on ﬂuoroscopy venograms with
LV epicardial surface on SPECT MPI for image-guided
LV lead placement and to evaluate its technical
accuracy and clinical feasibility.
METHODS
PATIENT DATA. This study included 10 patients who
underwent CRT because of standard indications.
These patients had SPECT MPI before CRT,ﬂuoroscopic venography during CRT, and computed
tomography (CT) venography after CRT. The baseline
characteristics of these patients are listed in Table 1.
The pre-CRT SPECT scan was performed app-
roximately 30 min after injection of 20 to 30 mCi of
Tc-99m sestamibi. SPECT images were acquired on
a dual-headed camera (CardioMD, Philips Medical
Systems, Milpitas, California) using a standard resting
protocol. The acquisition parameters were 20% energy
window around 140 KeV, 180 orbit, 32 steps with 25 s
per step, 8-bin gating, and 64 projections per gate. The
pixel size of images was 6.4  6.4  6.4 mm3.
All patients underwent standard CRT implantation.
During CRT implantation, retrograde ﬂuoroscopy
venograms, with in-plane pixel size of 0.3  0.3 mm2
were obtained by placing a venogram balloon cath-
eter in the coronary sinus. Dual-view ﬂuoroscopic
venograms were acquired from the left anterior obli-
que (LAO) 45 and anteroposterior (AP) orientations.
Contrast-enhanced CT venograms were acquired
using a 64-slice CT scanner within 1 week after the
CRT procedure. A standard protocol of CT angiog-
raphy was modiﬁed to image the venous system. The
imaging time was delayed by an additional 8 to 10 s
beyond the arterial scan timing. The pixel size of the
CT image was 0.38  0.38  0.38 mm3.
Figure 1 shows the major steps of this study. 3D LV
venous anatomy was reconstructed from the ﬂuoro-
scopic venograms. LV epicardial surface and land-
marks were extracted from the SPECT images and then
fused with the 3D LV venous anatomy. CT epicardial
surface and venous anatomy were extracted from the
CT venograms and registered to the SPECT epicardial
surface. The locations of the ﬂuoroscopic and CT veins
Fluoroscopy Image Processing
Fluoroscopic Venous Anatomy
Fluoroscopy Venograms
SPECT Image Processing
Evaluation of  SPECT-vein Fusion Accuracy
SPECT-vein Fusion
SPECT Epicardial Surface 
and Interventricular Grooves
SPECT MPI Images
CT Image Processing
CT Epicardial Surface 
and CT Venous Anatomy
CT Venograms
SPECT-CT Fusion
FIGURE 1 Major Steps of SPECT-Vein Fusion and Its Validation
Three-dimensional (3D) left ventricular (LV) venous anatomy was reconstructed from ﬂuoroscopic venograms. LV epicardial surface and
interventricular grooves were extracted from single-photon emission computed tomography (SPECT) images. The SPECT-vein fusion integrated
3D LV venous anatomy onto SPECT epicardial surface. CT epicardial surface and venous anatomy were extracted from the CT venograms and
registered to the SPECT epicardial surface to evaluate the accuracy of the SPECT-vein fusion. MPI ¼ myocardial perfusion imaging.
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1241on the SPECT epicardial surface were compared to
evaluate the accuracy of the 3D fusion tool kit.
FLUOROSCOPIC IMAGE PROCESSING. Figure 2
demonstrates the processing steps to generate 3D
LV venous anatomy from the dual-view ﬂuoroscopy
venograms.
The ﬁrst step was to select an LAO frame and an AP
frame from the dual-view ﬂuoroscopic venograms, asFIGURE 2 Workﬂow Diagram of Fluoroscopic Image Processing
(A) Selection of the best-matched frames from left anterior oblique (LA
veins marked with red arrows were not drawn because they were on th
geometry calibration. (D) Reconstructed 3D venous anatomy in LAO andshown in Figure 2A. The selected frames should
contain clear venous anatomy and approximately
correspond to the end-diastolic time point over the
cardiac cycle.
A semiautomatic algorithm was used to extract the
centerlines of the major veins. An interactive tool was
developed for the operator to manually identify the
major veins and pair them accordingly. The majorO) and anteroposterior (AP). (B) The centerlines of major veins. The
e right ventricle. (C) Bifurcations (red points) for dual-view imaging
AP views. Abbreviation as in Figure 1.
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1242veins include, but are not limited to, coronary sinus
(CS), great cardiac vein (GCV), anterior vein (AV), left
marginal vein (LMV), posterior vein (PV), and middle
cardiac vein (MCV). The tracked venous branches
should be clearly visible on the ﬂuoroscopic images,
as shown in Figure 2B.
The following step was to establish the topology of
the venous anatomy. The tracked vessels were auto-
matically connected to identify the bifurcations of the
major veins. Because the LAO and AP ﬂuoroscopic
images were not acquired simultaneously, the iso-
centers of the 2 images could be different. Thus, a
calibration algorithm on the basis of multiobjective
optimization was used to calculate the locations of
the isocenters using the system-provided geometric
parameters and the identiﬁed bifurcations as shown
in Figure 2C. The multiobjective function was the
summation of 2 equally weighed components: the
back-projection error (8) and the projection–back-
projection mismatch error (9), illustrated as the red
lines in Figure 3. A genetic algorithm, which simulates
the natural selection process to ﬁnd the globally
optimal solution (9), was used to minimize the
objective function to calibrate the isocenters.
The next step was to pair the points between the
corresponding vessel segments on the LAO and AP
images. For the segments between 2 bifurcations
(green lines in Figure 2C), linear interpolation was
used to pair the points within the segments. For
the segments with an open ending (blue lines in
Figure 2C), a dynamic programming technique wasFIGURE 3 Bifurcation-Based Calibration for Reconstructing 3D Veno
(A) Back-projection of the matched bifurcations. P and Q are the matched
the x-ray source from the LAO and AP directions, respectively. C is the m
distance between the 2 back-projection lines PS and QR. The length of th
reprojected from R and S through C to the LAO and AP planes, respective
projection mismatch error. Abbreviations as in Figures 1 and 2.used to establish the point correspondence. The
dynamic programming technique searched for all
possible point correspondences and identiﬁed the
optimal one, which minimized the total back-
projection error (10).
Finally, 3D venous anatomy was reconstructed by
backprojecting the matched point pairs with the
calibrated ﬂuoroscopic imaging parameters, as shown
in Figure 2D.
SPECT IMAGE PROCESSING. Figure 4 shows the
interface used to manually identify LV parameters
and landmarks on the reconstructed SPECT image.
Once the LV parameters and landmarks were identi-
ﬁed, an automatic algorithm was used to construct
the 3D epicardial surface. The algorithm searched in
3D for the maximal count circumferential proﬁles on
the short-axis images (11,12), which represented the
myocardial mass contour. Then a line proﬁle of the
myocardial wall along the myocardium’s radius
of sampling was created for each sample of the
myocardial mass contour. Gaussian functions were ﬁt
to the line proﬁles; 50% of the maximal counts of
the ﬁtted line proﬁles represented the epicardial
surface (13).
3D FUSION OF SPECT EPICARDIAL SURFACE
AND FLUOROSCOPIC VENOUS ANATOMY. The
SPECT-vein fusion consisted of 3 steps: geometric
alignment, landmark-based registration, and vessel-
surface overlay. In geometric alignment, the geo-
metric parameters in the images’ DICOM headers,us Anatomy From Dual-View Fluoroscopy Imaging
bifurcations on the dual-view projections. R and S are the positions of
iddle point of the line segment (red line) that represents the minimal
e line segment is the back-projection error. (B) P’ and Q’ are the points
ly. The total distance of PP’ and QQ’ (red lines) is the projection–back-
FIGURE 4 User Interface Used to Identify LV Parameters and Landmarks
The LV parameters included center, radius, apex, and base. The landmarks included anterior and posterior interventricular grooves and
atrioventricular groove, which was considered the same as the LV base. RV ¼ right ventricular; other abbreviation as in Figure 1.
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1243such as rotation centers and angles, and pixel sizes
were used to align the 3D LV venous anatomy and
SPECT epicardial surface into the same short-axis
view. Then landmark-based registration was applied
to improve alignment. It was a rigid registration on
the basis of the landmarks illustrated in Figure 5A
(14): 1) CS and GCV approximately course the atrio-
ventricular groove, which was considered the same as
the LV basal short-axis slice; and 2) AV and MCV
approximately course the anterior and posterior
interventricular grooves, respectively. The landmark-
based registration method used a least-square-error
algorithm, which minimized the total square error of
the distances between the landmarks on the SPECT
image and the corresponding vessels on the 3D
venous anatomy. After the landmark-based registra-
tion, the vessels were overlaid onto the LV epicardial
surface using a vessel-surface overlay algorithm (15),
which wrapped each point of the vessel centerlines to
the epicardial surface along the line proﬁles of the
epicardial sampling, as shown in Figure 5B.
EVALUATION OF THE SPECT-VEIN FUSION. The
accuracy of the SPECT-vein fusion was evaluated
using the post-implant CT venograms. CT images
were reconstructed by the standard ﬁltered back-
projection algorithm and then manually processed
by experienced operators, who were blinded from
the ﬂuoroscopic images and the landmarks on the
SPECT images. The manual processing includedsegmentation of the 3D epicardial surface from the CT
images, identiﬁcation of the major veins on the CT
epicardial surface, and rigid registration of the CT and
SPECT epicardial surfaces. The rigid transformation
was also applied to the identiﬁed CT veins, so that
they were closely aligned with the SPECT epicardial
surface. The same vessel-surface overlay algorithm as
in the SPECT-vein fusion was used to overlay the CT
veins onto the SPECT epicardial surface, which then
served as the reference standards to evaluate the
accuracy of the 3D fusion tool kit.
Figure 6A shows the rendered CT LV volume with
the LV veins in 1 patient example. The rendered CT
LV volumetric image demonstrated the landmarks
used in the SPECT-vein fusion: CS and GCV are well
matched with the LV base, and AV and MCV are well
matched with the interventricular grooves (black
lines), respectively. Figure 6B shows that the ﬂuoro-
scopic and CT veins are closely aligned on the
SPECT epicardial surface and their distance is small
compared with the segmental size of the American
Heart Association (AHA) 17-segment model.
Two metrics were used to quantitatively assess the
accuracy of the SPECT-vein fusion:
1. The distance-based mismatch error on the epicar-
dial surface. It is the short-axis view point-to-point
distance between the ﬂuoroscopic and CT veins on
the SPECT LV epicardial surface, as illustrated by
FIGURE 5 Illustration of the SPECT-Vein Fusion
(A) Landmark-based registration. The coronary sinus (CS) and great cardiac vein (GCV) are registered to the LV base (green line). The anterior
vein (AV) and middle cardiac vein (MCV) are registered to the anterior and posterior interventricular grooves (red lines), respectively. (B)
Vessel-surface overlay. The white lines are the vessels after landmark-based registration that are overlaid onto the epicardial surface (purple
lines) by the vessel-surface overlay algorithm. L is LV long-axis line passing through the LV sampling center illustrated in Figure 4; P is a point
on the registered vessels. The overlaid point Q of P is the intersection between the LV epicardial surface and the projection line from P that is
perpendicular to L. Abbreviations as in Figure 1.
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1244the red line in Figure 6B. If the ﬂuoroscopic and CT
vessel lengths were different, distances were only
measured when both were present in the same
short-axis slice. The thickness of the short-axis
slice used in the evaluation was 1.33 mm, which
is approximately the size of typical LV lead tips.
2. The segment-based kappa agreement rate using
AHA 17-segment model. The 17 segments were
rendered on the epicardial surface. Then the pres-
ence of the ﬂuoroscopic and that of the CT veins in
these segments were compared to calculate the
kappa agreement rates for all veins and the indi-
vidual veins, respectively.PROSPECTIVE CLINICAL STUDY. A prospective clin-
ical study with 1 patient, who had CRT implantation
because of standard indications, was conducted in
the Department of Cardiology, The First Afﬁliated
Hospital of Nanjing Medical University, Nanjing,
Jiangsu, China. This patient (68-year-old man) had
dilated cardiomyopathy with New York Heart Asso-
ciation functional class II, low LV ejection fraction
(32%), and wide QRS duration (168 ms). This patient
had pre-CRT SPECT MPI to identify the optimal LV
lead position. The SPECT-vein fusion software was
loaded on a laptop computer and used to guide LV
lead placement during CRT in the catheterization
FIGURE 6 Comparison of CT and Fluoroscopic Veins
(A) LV coronary veins on the CT venogram (black lines outline the anterior and posterior interventricular grooves). (B) LV coronary veins from
the CT and ﬂuoroscopy venograms overlaid on the SPECT epicardial surface. The differences between the ﬂuoroscopic and CT veins on the
epicardial surface, as illustrated by the red arrow, were used to evaluate the accuracy of the SPECT-vein fusion. AHA ¼ American Heart
Association; other abbreviations as in Figure 1.
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1245laboratory. Post-implant electrocardiograms (ECGs)
were acquired at CRT device ON and OFF. The patient
was followed up by echocardiography at approxi-
mately 1 month post-CRT.
RESULTS
ACCURACY OF THE SPECT-VEIN FUSION. Table 2
shows the distance-based mismatch errors between
the ﬂuoroscopic and CT veins. The distance-based
mismatch errors between the ﬂuoroscopic and CT
veins were 4.3  3.0 mm, 2.9  2.9 mm, 3.1  2.8 mm,
and 7.3  3.6 mm for AV, MCV, LMV, and PV,
respectively. The overall distance-based mismatch
error for the entire population was 4.6  3.6 mmTABLE 2 Distance-Based Mismatch Errors Between the
Fluoroscopic and CT Veins on the SPECT Epicardial Surface
Number of Point Pairs
Mismatch Error, mm
Mean  SD Minimum Maximum
AV 360 4.3  3.0 0.0 16.0
MCV 158 2.9  2.9 0.8 13.4
LMV 256 3.1  2.8 0.1 14.4
PV 285 7.3  3.6 0.2 16.9
Overall 1,059 4.6  3.6 0.0 16.9
AV ¼ anterior vein; CT = computed tomography; LMV ¼ left marginal vein; MCV ¼
middle cardiac vein; PV ¼ posterior vein; SPECT ¼ single-photon emission
computed tomography.(minimum 0 mm; maximum 16.9 mm). The largest
overall mismatch error for a single patient was 7.9 
3.1 mm (minimum 0.2 mm; maximum 13.1 mm).
Table 3 shows the segment-based mismatch errors
between the ﬂuoroscopic and CT veins on the SPECT
epicardial surface. The kappa agreement rates were
0.88, 0.87, 0.91, and 0.84 for the AV, MCV, LMV and
PV, respectively. The overall kappa agreement rate
for all veins was 0.87 (95% conﬁdence interval: 0.82
to 0.93). In all cases where the presence of the ﬂuo-
roscopic and CT veins did not match in the same
segments, they were located in the immediately
adjacent segments.
Noteworthy, for the fusion accuracy of individual
veins as shown in Tables 2 and 3, the fusion was least
accurate for PV because: 1) AV and MCV were used as
the landmarks, and so their fusion accuracy was
higher; and 2) PV was usually longer in length and
more distant from the landmarks than LMV. Never-
theless, it should not impact the clinical utility of the
fusion tool kit. The longer the vessel, the closer its
distal site is to the LV apex, which is suggested to be
avoided for CRT LV lead placement (16).
PROCESSING TIME. All image processing ran on a
personal computer with 3.40 GHz CPU, 8 GB memory,
and Windows 7 operation system (Microsoft, Red-
mond, Washington). In ﬂuoroscopy image processing,
the reconstruction of 3D venous anatomy required
TABLE 3 Segment-Based Mismatch Errors Between the
Fluoroscopic and CT Veins on the SPECT LV Epicardial Surface
CT-Y CT-N
AV
Fluoro-Y 27 3
Fluoro-N 3 137
Kappa 0.88
95% CI 0.78–0.97
PV
Fluoro-Y 22 3
Fluoro-N 4 141
Kappa 0.84
95% CI 0.72–0.96
MCV
Fluoro-Y 15 3
Fluoro-N 1 151
Kappa 0.87
95% CI 0.74–1.00
LMV
Fluoro-Y 23 1
Fluoro-N 3 143
Kappa 0.91
95% CI 0.82–1.00
Overall
Fluoro-Y 87 10
Fluoro-N 11 572
Kappa 0.87
95% CI 0.82–0.93
CI ¼ conﬁdence interval; CT-N ¼ total number of segments without CT veins;
CT-Y ¼ total number of segments with CT veins; Fluoro-N ¼ total number of
segments without ﬂuoroscopic veins; Fluoro-Y ¼ total number of segments with
ﬂuoroscopic veins; LV ¼ left ventricle; other abbreviations as in Table 2.
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1246approximately 18  8 s. In SPECT image processing,
the construction of epicardial surface consumed 82 
20 s. The SPECT-vein fusion consumed 22  10 s.
The interactive identiﬁcation of the vein center-
lines from ﬂuoroscopic venograms was the time
bottleneck because SPECT image processing can be
done before implantation and the fusion step can be
done automatically within 1 min. In this study, the
time to interactively identify venous centerlines was
approximately 5 min.
PROSPECTIVE CLINICAL STUDY. Figure 7 shows the
prospective clinical study. Pre-implant SPECT was
used to identify the optimal LV lead position, which
was the mid anterior myocardial segment. As shown
in Figure 7A, the middle segment of the anterior vein
was close to the optimal segment, and therefore, it
was targeted for LV lead placement. The post-implant
ﬂuoroscopy in Figure 7B shows that the LV lead was
placed in the targeted position. The post-CRT ECG
with the CRT device ON and OFF in Figure 7C showed
that the QRS duration was signiﬁcantly narrowed
(from 168 to 140 ms) after the device was turned on.It took approximately 6 min for the software to
produce the 3D SPECT-vein fusion results. Most of the
time was spent on the step to manually draw the LV
veins on the ﬂuoroscopic images.
This patient had been followed up with echocar-
diography at 1 month post-CRT. From baseline to the
1-month follow-up, his LV diastolic diameter
decreased from 64 to 53 mm, and his LVEF increased
from 32% to 57%. It clearly conﬁrmed that the image-
guided LV lead placement resulted in a super
response to CRT.DISCUSSION
This is the ﬁrst study to integrate 3D venous anatomy
from ﬂuoroscopy venograms with the SPECT epicar-
dial surface for guiding CRT LV lead placement. The
distance-based mismatch errors between the ﬂuoro-
scopic and CT veins on the SPECT epicardial surfaces
were small compared with the segmental size of the
AHA 17-segment model (w30  30 mm2), even for the
patient with the largest distance-based mismatch
error (16.9 mm). Consequently, the presence of the
ﬂuoroscopic and CT veins in the segments agreed
well, with all kappa values greater than 0.80, as
shown in Table 3. The clinical feasibility of the 3D
fusion tool kit was conﬁrmed by a prospective clinical
study guiding LV lead placement during CRT in the
catheter laboratory. In summary, this study showed
that the 3D fusion tool kit was technically accurate
and clinically effective to fuse ﬂuoroscopic venous
anatomy and SPECT epicardial surface for guiding
CRT LV lead placement.
EX IST ING NAVIGAT ION STRATEGIES OF LV
LEAD PLACEMENT. The TARGET trial (6) used a
2-dimensional (2D) visual correspondence method,
which aligned the venous anatomy from steep LAO
ﬂuoroscopic venograms with the short-axis para-
sternal echocardiographic view. As a result, two-
thirds of the patients had LV leads placed in the
recommended positions. The STARTER (Speckle
Tracking Assisted Resynchronization Therapy for
Electrode Region) trial (5) used a similar visual cor-
respondence method: the anterior, lateral, and pos-
terior segments assessed on the LAO ﬂuoroscopy
venograms were aligned with the corresponding
segments on the echocardiographic images; in addi-
tion, the right anterior oblique venograms were used
to assess the basal, middle, and apical segments.
Consequently, the exact concordance between the
recommended segments and LV lead positions was
achieved in only 30% of the patients in the guided
group, and the number increased to 85% of the
FIGURE 7 Prospective Clinical Study With SPECT-Vein Navigation Tool Kit
(A) Target venous site for LV lead placement. Major LV veins were drawn on ﬂuoroscopic venograms, reconstructed to a 3D structure, and fused
with SPECT LV epicardial surface. The mid part of AV (blue line) was aligned with the optimal segment (white segment) and so was targeted
for lead placement. (B) Post-implant ﬂuoroscopy. The LV lead was placed using the guidance in (A). The post-implant images show that the LV
lead (red arrows) was on target. (C) Post-implant electrocardiogram. The QRS duration decreased from 168 to 140 ms immediately after the
cardiac resynchronization therapy (CRT) device was turned on. RAO ¼ right anterior oblique; other abbreviations as in Figures 1, 2, and 5.
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1247patients when segments immediately adjacent to the
recommended site were included. As the 2 trials
showed, visual correspondence of the venous anat-
omy and myocardial segments was not accurate in
many patients. Therefore, the registration of the
2 types of images is needed.
Ma et al. (17) used pre-procedural CMR imaging to
assess venous anatomy, projected the 3D LV epicar-
dial surface extracted from the CMR images onto
the 2D intraoperative ﬂuoroscopic venograms, and
then manually registered them using multiple views
of a catheter looped in the right atrium. A similar
method based in cardiac CT is being validated in an
ongoing clinical trial (18). All of these methods pro-
vide only 2D navigability and require anatomic
imaging.
The methodology in this study uniﬁed LV venous
anatomy onto the LV myocardial wall in 3D and thus
allowed 3D navigation, such as translation, rotation,
and scale, to conveniently identify the target venous
branch and optimal site for LV lead placement. In
addition, our tool kit used the landmarks identiﬁed
on SPECT MPI for registration and did not require
additional anatomic imaging. This is clinically
important because it will reduce the radiation dosage
and save operational costs and scanning time. In
addition, the fusion technique is automatic; there-
fore, it has potentially less user variability than
manual registration techniques.CLINICAL APPLICABILITY. The availability and reli-
ability of the landmarks is the most essential factor
for the clinical applicability of the SPECT-vein fusion
tool. Despite the large variations of LV venous anat-
omy in CRT patients, the anatomic correspondence
used in the landmark-based registration of this tool
constantly exists. In addition, the timing of ﬂuoro-
scopic image acquisition may inﬂuence the visibility
of the veins, especially the MCV, where the contrast
agent enters later than other branches. Because
the MCV was not considered for LV lead placement in
the majority of patients, recordings of the ﬂuoro-
scopic images were usually terminated when other
veins were clearly visualized. Therefore, in 5 of 10
patients, only the upper portion of the MCV was
clearly visible but not the entire branch. The fusion
accuracy was slightly lower in these patients with
short visible MCV than those with entire MCV (5.0
 3.3 mm vs. 4.3  3.8 mm; kappa ¼ 0.85 vs. 0.90),
indicating that the more landmark points used in the
landmark-based registration, the more accurate the
fusion was.
The clinical applicability of the 3D fusion tool kit
was conﬁrmed in the prospective clinical study
shown in Figure 7. During the procedure, the elec-
trophysiologist frequently returned to our tool kit and
referred to the results with 3D navigation. The tool kit
took approximately 6 min to process the images and
target the venous site for LV lead placement. It was
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1248quite short compared with the time of the entire CRT
procedure (approximately 2 h).
STUDY LIMITATIONS. The technical accuracy and
clinical feasibility of the 3D fusion tool kit were tested
in a relatively small sample size. A prospective vali-
dation in a larger population with a control or com-
parison group is needed to establish the clinical
usefulness of this technique.
CONCLUSIONS
A tool kit has been developed to reconstruct 3D LV
venous anatomy from dual-view ﬂuoroscopic veno-
grams and to fuse it with the LV epicardial surfaceon SPECT MPI. It is technically accurate for guiding
LV lead placement by the AHA 17-segment model
and is feasible for clinical use in the catheterization
laboratory.
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